Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Verici Dx (VRCI) Share Price

Price 0.725p on 15-01-2026 at 18:00:08
Change -0.025p -3.33%
Buy 0.75p
Sell 0.70p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 5,500.00 at 0.7025p
Day's Volume: 1,793,017
Last Close: 0.725p
Open: 0.75p
ISIN: GB00BM8HZD43
Day's Range 0.725p - 0.75p
52wk Range: 0.48p - 4.25p
Market Capitalisation: £10.97m
VWAP: 0.728704p
Shares in Issue: 1.51b

Sector: Medicine and Biotech

Listed In: FTSE AIM All-Share,

Verici Dx (VRCI) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 5,500 0.7025p Ordinary
 16:19:06 - 15-Jan-26
Buy* 147,033 0.74p Ordinary
 11:00:41 - 15-Jan-26
Sell* 75,000 0.715p Ordinary
 08:23:07 - 15-Jan-26
Sell* 624 0.70p SI Trade
 08:19:30 - 15-Jan-26
Sell* 564,860 0.73p Ordinary
 08:19:27 - 15-Jan-26
Sell* 500,000 0.7275p Ordinary
 08:19:08 - 15-Jan-26
Sell* 500,000 0.7275p Ordinary
 08:18:49 - 15-Jan-26
Buy* 100,000 0.7675p Ordinary
 11:23:31 - 14-Jan-26
Buy* 130 0.7675p Ordinary
 10:39:41 - 14-Jan-26
Sell* 216,802 0.725p Ordinary
 10:35:24 - 14-Jan-26
See more Verici Dx trades

Verici Dx (VRCI) Share Price History

Time period:
to
Date Open High Low Close Volume
15th Jan 2026 (Thu) 0.75 0.75 0.725 0.725 1,793,017
14th Jan 2026 (Wed) 0.75 0.75 0.75 0.75 318,242
13th Jan 2026 (Tue) 0.75 0.75 0.75 0.75 216,607
12th Jan 2026 (Mon) 0.75 0.75 0.75 0.75 19,299
9th Jan 2026 (Fri) 0.75 0.75 0.725 0.75 1,087,995
8th Jan 2026 (Thu) 0.75 0.75 0.75 0.75 232,017
7th Jan 2026 (Wed) 0.725 0.75 0.725 0.75 626,703
6th Jan 2026 (Tue) 0.725 0.725 0.725 0.725 528,795
5th Jan 2026 (Mon) 0.725 0.75 0.725 0.725 448,850
2nd Jan 2026 (Fri) 0.725 0.725 0.725 0.725 350,799
1st Jan 2026 (Thu) 0.725 0.725 0.725 0.725 0
31st Dec 2025 (Wed) 0.75 0.75 0.725 0.725 336,014
30th Dec 2025 (Tue) 0.775 0.775 0.75 0.75 1,610,892
29th Dec 2025 (Mon) 0.775 0.775 0.775 0.775 683,580
26th Dec 2025 (Fri) 0.775 0.775 0.775 0.775 0
25th Dec 2025 (Thu) 0.775 0.775 0.775 0.775 0
24th Dec 2025 (Wed) 0.775 0.775 0.775 0.775 250,263
23rd Dec 2025 (Tue) 0.775 0.775 0.775 0.775 319,330
22nd Dec 2025 (Mon) 0.775 0.775 0.775 0.775 1,019,488
19th Dec 2025 (Fri) 0.775 0.775 0.775 0.775 687,996
18th Dec 2025 (Thu) 0.775 0.775 0.775 0.775 992,475
17th Dec 2025 (Wed) 0.775 0.775 0.775 0.775 2,181,048
16th Dec 2025 (Tue) 0.85 0.85 0.775 0.775 2,877,162
See more Verici Dx price history

Verici Dx (VRCI) Regulatory News

Date Source Headline
12th Nov 2025 7:00 am RNS-R Completion of CAP accreditation audit
6th Nov 2025 7:00 am RNS Provider Participation Agreement with Prime Health
3rd Nov 2025 7:00 am RNS-R Completion of ISO 27001 surveillance audit
30th Oct 2025 7:00 am RNS Options revision & Grant of new share options
6th Oct 2025 7:01 am RNS Board Changes
6th Oct 2025 7:00 am RNS Update on Tutivia™ test adoption
1st Oct 2025 4:55 pm RNS Holding(s) in Company
30th Sep 2025 7:00 am RNS Half-year Report
1st Aug 2025 10:40 am RNS Holding(s) in Company
31st Jul 2025 5:33 pm RNS Holding(s) in Company
See more Verici Dx regulatory news

Verici Dx (VRCI) Share News

IN BRIEF: Verici passes laboratory inspection by US accreditor

12th Nov 2025 18:05

Verici Dx PLC - Cardiff, Wales-based developer of advanced clinical diagnostics for organ transplants - Completes second biennial inspection of its clinical laboratory, accredited by the College of American Pathologists. Verici says the inspection, passed with no deficiencies, shows its "commitment to compliance and maintaining excellence in daily clinical laboratory operations according to CAP requirements". Adds: "By continuing to follow these strict CAP guidelines and pass CAP accreditation audits, Verici Dx can consistently provide reliable test results under its quality management system and further improve patient health." Read More

AIM WINNERS & LOSERS: Quantum Blockchain launches new software version

12th Nov 2025 11:20

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Wednesday. Read More

AIM WINNERS & LOSERS: Asiamet to sell project stake; Ethernity sinks

6th Nov 2025 11:04

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More

TRADING UPDATES: Northcoders contract wins; Verici Dx completes audit

3rd Nov 2025 21:58

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: Verici Dx shares jump as posts progress on Tutivia adoption

6th Oct 2025 11:50

Verici Dx PLC - Cardiff, Wales-based developer of advanced clinical diagnostics for organ transplants - Reports "positive progress" in its plans to drive sales growth for Tutivia, its flagship kidney transplant diagnostic test. Says commercial scale-up of Tutivia test adoption has progressed in the third quarter with ordering clinicians rising 19%. Verici has also onboarded nine new transplant centres, bringing the total to 30 centres which represent 16% of annual transplants in the US. Says orders in the third quarter were consistent with the previous two, and expects volume growth in the fourth. Company also says it has expanded its commercial team with three new senior sales hires; a new director of clinical partnerships joins in mid-October; and Aubrey Powell joins the board as a non-executive director with Mount Sinai representative Erik Lium stepping down. The firm continues "to target meeting expectations" for its full-year 2025 results. Read More

See more Verici Dx news
FTSE 100 Latest
Value10,238.94
Change54.59

Login to your account

Forgot Password?

Not Registered